{"schema_version":"alpha-profile-public-v1","slug":"john-r-pinion-ii","canonical_url":"https://registry.alpha.ac/people/john-r-pinion-ii","as_of":"2026-09-17T03:32:15.943747+00:00","published_at":"2026-09-02T04:20:44.357425+00:00","last_reviewed_at":"2026-09-12T18:07:23.013453+00:00","identity":{"display_name":"John R. Pinion II","headshot_url":null,"headshot_media":null,"profile_kind":"executive","role_tags":["executive"],"current_role":{"company_name":"Ultragenyx Pharmaceutical Inc.","company_slug":"ultragenyx-pharmaceutical-inc","exchange":"NASDAQ","ticker":"RARE","role_category":"officer","title":"Chief Quality Officer and Executive Vice President of Translational Sciences","committee":null,"is_board_chair":false,"is_independent":null,"valid_from":null,"valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.95,"evidence":{"source_type":"sec_def_14a","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=john-r-pinion-ii","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=john-r-pinion-ii&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Pinion has served as Chief Quality Officer and Executive Vice President of Translational Sciences since September 2017, with prior roles at Genentech from 2005 to 2015 including SVP and Global Head of Quality and Compliance for Roche/Genentech Pharma Technical Operations. He holds a B.S. in Mechanical Engineering from the University of West Virginia."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Ultragenyx Pharmaceutical Inc.","company_slug":"ultragenyx-pharmaceutical-inc","exchange":"NASDAQ","ticker":"RARE","role_category":"officer","title":"Chief Quality Officer and Executive Vice President of Translational Sciences","committee":null,"is_board_chair":false,"is_independent":null,"valid_from":null,"valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.95,"evidence":{"source_type":"sec_def_14a","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for John R. Pinion II as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:56:20.435627+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RARE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","published_at":"2026-03-27T00:00:00+00:00","last_checked_at":"2026-05-05T00:56:20.26002+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for John R. Pinion II as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:56:20.480056+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RARE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","published_at":"2026-03-27T00:00:00+00:00","last_checked_at":"2026-05-05T00:56:20.26002+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Ultragenyx Pharmaceutical Inc.","claim_text":"John R. Pinion II is associated with Ultragenyx Pharmaceutical Inc..","claim_state":"verified","valid_from":"2026-03-27","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:56:20.410888+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RARE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","published_at":"2026-03-27T00:00:00+00:00","last_checked_at":"2026-05-05T00:56:20.26002+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Quality Officer and Executive Vice President of Translational Sciences","claim_text":"John R. Pinion II is listed as Chief Quality Officer and Executive Vice President of Translational Sciences at Ultragenyx Pharmaceutical Inc..","claim_state":"verified","valid_from":"2026-03-27","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:56:20.386872+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RARE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","published_at":"2026-03-27T00:00:00+00:00","last_checked_at":"2026-05-05T00:56:20.26002+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for John R. Pinion II as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-05T00:56:20.456859+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"RARE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","published_at":"2026-03-27T00:00:00+00:00","last_checked_at":"2026-05-05T00:56:20.26002+00:00","relation":"supports","excerpt_locator":null}]}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/john-r-pinion-ii#profile","url":"https://registry.alpha.ac/people/john-r-pinion-ii","dateModified":"2026-09-12T18:07:23.013453+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/john-r-pinion-ii#person","name":"John R. Pinion II","url":"https://registry.alpha.ac/people/john-r-pinion-ii","jobTitle":"Chief Quality Officer and Executive Vice President of Translational Sciences","worksFor":{"@type":"Organization","name":"Ultragenyx Pharmaceutical Inc.","tickerSymbol":"NASDAQ: RARE"},"affiliation":[{"@type":"OrganizationRole","roleName":"Chief Quality Officer and Executive Vice President of Translational Sciences","memberOf":{"@type":"Organization","name":"Ultragenyx Pharmaceutical Inc.","url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","tickerSymbol":"NASDAQ: RARE"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","name":"RARE DEF 14A executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/john-r-pinion-ii"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":6,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":6,"corroborated_claims":0,"sources":2,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-09-12T18:07:23.013453+00:00","observed_at":"2026-09-17T03:32:15.943747+00:00","freshness_days":4}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"john-r-pinion-ii","canonical_url":"https://registry.alpha.ac/people/john-r-pinion-ii"},"publication":{"published_at":"2026-09-02T04:20:44.357425+00:00","last_reviewed_at":"2026-09-12T18:07:23.013453+00:00","as_of":"2026-09-17T03:32:15.943747+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/john-r-pinion-ii","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/john-r-pinion-ii","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/john-r-pinion-ii.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}